Viewing Study NCT03517566


Ignite Creation Date: 2025-12-24 @ 4:09 PM
Ignite Modification Date: 2025-12-25 @ 2:09 PM
Study NCT ID: NCT03517566
Status: TERMINATED
Last Update Posted: 2021-10-08
First Post: 2018-03-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-11-14
Start Date Type: ACTUAL
Primary Completion Date: 2020-07-15
Primary Completion Date Type: ACTUAL
Completion Date: 2020-08-06
Completion Date Type: ACTUAL
First Submit Date: 2018-03-27
First Submit QC Date: None
Study First Post Date: 2018-05-07
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-04-07
Results First Submit QC Date: None
Results First Post Date: 2021-07-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-07
Last Update Post Date: 2021-10-08
Last Update Post Date Type: ACTUAL